Abstract
Spectinomycin, a tricyclic aminoglycoside antibiotic with peculiar chemical structure and pharmacological profile was characterized in terms of microscopic protonation constants. 1H-15N HMBC–pH titrations were carried out to allocate the order of basicities of the two similar methylamino functions of spectinomycin, and 1H NMR–pH titrations were performed on spectinomycin and actinamine, its symmetrical model compound to determine the basicity of the amino sites. It was found that the methylamino moiety in position 3 is of some 60% higher basicity than its counterpart in position 1, and protonation at one site decreases the basicity of the other site by 1.17 logk units. Both secondary amino sites as such are of relatively low basicity, due to the adjacent, electron-withdrawing 7 oxygens. At the pH of blood nearly equal amounts of di- and monocationic species coexist, while less than 1% of neutral spectinomycin occurs at this pH. The pHdependent distribution of the microspecies is depicted.
Keywords: Spectinomycin, microspeciation, 1H and 15N NMR-pH titration, site-specific basicities, pH-dependent species distribution.
Current Pharmaceutical Analysis
Title:The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods
Volume: 11 Issue: 1
Author(s): Mate Somlyay, Gabor Orgovan and Bela Noszal
Affiliation:
Keywords: Spectinomycin, microspeciation, 1H and 15N NMR-pH titration, site-specific basicities, pH-dependent species distribution.
Abstract: Spectinomycin, a tricyclic aminoglycoside antibiotic with peculiar chemical structure and pharmacological profile was characterized in terms of microscopic protonation constants. 1H-15N HMBC–pH titrations were carried out to allocate the order of basicities of the two similar methylamino functions of spectinomycin, and 1H NMR–pH titrations were performed on spectinomycin and actinamine, its symmetrical model compound to determine the basicity of the amino sites. It was found that the methylamino moiety in position 3 is of some 60% higher basicity than its counterpart in position 1, and protonation at one site decreases the basicity of the other site by 1.17 logk units. Both secondary amino sites as such are of relatively low basicity, due to the adjacent, electron-withdrawing 7 oxygens. At the pH of blood nearly equal amounts of di- and monocationic species coexist, while less than 1% of neutral spectinomycin occurs at this pH. The pHdependent distribution of the microspecies is depicted.
Export Options
About this article
Cite this article as:
Somlyay Mate, Orgovan Gabor and Noszal Bela, The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods, Current Pharmaceutical Analysis 2015; 11 (1) . https://dx.doi.org/10.2174/1573412910666140917213713
DOI https://dx.doi.org/10.2174/1573412910666140917213713 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Long Pentraxin PTX3, a Soluble Pattern Recognition Receptor Involved in Innate Immunity,Inflammation and Female Fertility
Current Immunology Reviews (Discontinued) Synthesis of Nitrogen and Oxygen based Pyrazole Derivatives and Its Antitubercular and Antimicrobial Activity
Anti-Infective Agents Can Probiotics Cure Inflammatory Bowel Diseases?
Current Pharmaceutical Design A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase
Current Medicinal Chemistry Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery
Current Medicinal Chemistry Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria
Current HIV Research Synthesis and Anti-mycobacterium Study on Halo-substituted 2-aryl oxyacetohydrazones
Current Computer-Aided Drug Design Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics
Current Pharmaceutical Design Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis
Current Drug Delivery Design, Synthesis and Antimycobacterial Activity of Some New Azaheterocycles: Phenanthroline with p-halo-benzoyl Skeleton. Part V
Letters in Drug Design & Discovery Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods
Combinatorial Chemistry & High Throughput Screening An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors
Current Drug Targets From the Old Immunitas to the Modern Immunity: Do We Need a New Name for the Immune System?
Current Immunology Reviews (Discontinued) Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD
Current Pharmaceutical Design Phenothiazine: A Better Scaffold against Tuberculosis
Mini-Reviews in Medicinal Chemistry